Sartorius's key customers are from the pharmaceutical, chemical and food and beverage industries and from numerous research and educational institutes of the public sector.
The supervisory board and the executive board of Sartorius resolved to suggest an increase in dividends of euro0.52 per preference share (previous year: euro0.42) and euro0.50 per ordinary share euro0.40) at the upcoming annual shareholder's meeting on 26 April 2006.
This means the distributed profit would increase 24.4% to euro8.7 million from euro7.0 million paid out for the previous fiscal year.
Upcoming financial dates:.
14 March 2006, annual press conference in Goettingen, Germany.
20 April 2006, three-month report 2006 to be published.
26 April 2006 annual shareholders' meeting in Goettingen, Germany.
Sartorius is a laboratory and process technology supplier covering the segments of biotechnology and mechatronics.
In 2005, the technology group earned sales revenue of euro484.3 million.
The Goettingen-based company founded in 1870 currently employs approx 3600 persons.
Its biotechnology segment focuses on filtration and separation products, bioreactors and proteomics.
The mechatronics segment manufactures, in particular, equipment and systems, which feature weighing, measurement and automation technology for laboratory and industrial applications, as well as hydrodynamic bearings.
Sartorius key customers are from the pharmaceutical, chemical and food and beverage industries and from numerous research and educational institutes of the public sector.
Sartorius has its own production facilities in Europe, Asia and America as well as sales subsidiaries and local commercial agencies in more than 110 countries.
